A. Canals

First‐time‐in‐human randomized clinical trial in healthy volunteers and haemodialysis patients with SNF472, a novel inhibitor of vascular calcification

P. Joubert, J. Perelló, S. Sinha, 2018, British journal of clinical pharmacology.

First-time-inhuman randomized clinical trial in healthy volunteers and haemodialysis patients with SNF 472 , a novel inhibitor of vascular calci fi cation

P. Joubert, J. Perelló, S. Sinha, 2018 .

A novel assay to measure calcification propensity: from laboratory to humans

J. Campistol, A. Gold, J. Perelló, 2020, Scientific Reports.

Improvement in wound healing, pain, and quality of life after 12 weeks of SNF472 treatment: a phase 2 open-label study of patients with calciphylaxis

A. Gold, P. Joubert, J. Perelló, 2019, Journal of Nephrology.

A phase 1b randomized, placebo‐controlled clinical trial with SNF472 in haemodialysis patients

J. Campistol, V. Torregrosa, P. Joubert, 2019, British journal of clinical pharmacology.

SP647FIRST-TIME-IN-HUMAN PHASE 1 CLINICAL TRIAL IN HEALTHY VOLUNTEERS WITH SNF472, A NOVEL INHIBITOR OF VASCULAR CALCIFICATION

P. Joubert, J. Perelló, M. Ferrer, 2015 .

Improvement in wound healing, pain, and quality of life after 12 weeks of SNF472 treatment: a phase 2 open-label study of patients with calciphylaxis

A. Gold, P. Joubert, J. Perelló, 2019, Journal of Nephrology.